Close Menu

Blogger Thomas Mailund muses about what he would do if $1,000 genomes were readily available in the next year. Since his focus is on finding disease associations, he says the big difference would come from the ability to detect more variants. "With SNP chips and tagging SNPs, we are looking for high-frequent variants with modest effect," he writes. "With full sequencing, we will be able to look for low frequency variants as well."

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.